Panacea Life Sciences Holdings, Inc.
PLSHOTCHealthcare● Active
$0.03
+$0.00(+0.00%)
Market Cap$679161
P/E Ratio—
52W High$0.1996
52W Low$0.0211
Panacea Life Sciences Holdings, Inc. (PLSH) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PLSH · as of 2026-06-16
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.42M) | ($0.58M) | ($8.02M) | ($9.14M) | ($4.78M) |
| Depreciation & Amort. | $1.77M | $1.15M | $1.71M | $1.73M | $0.97M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Change in Working Capital | ($4.63M) | ($1.51M) | $3.03M | $1.56M | $0.63M |
| Net Cash from Operations | $0.62M | $0.69M | ($1.52M) | ($2.40M) | ($3.92M) |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | ($0.00M) | ($0.07M) | ($0.24M) | ($0.16M) |
| Purchases of Investments | ($0.06M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.05M | $0.45M |
| Net Cash from Investing | ($0.06M) | $1.38M | ($0.07M) | ($0.20M) | $0.52M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($1.98M) | ($0.71M) | $1.68M | $2.58M | $3.33M |
| Net Cash from Financing | ($1.98M) | ($0.71M) | $1.68M | $2.58M | $3.33M |
| Free Cash Flow | |||||
| Free Cash Flow | $0.62M | $0.69M | ($1.59M) | ($2.64M) | ($4.09M) |
| FCF Margin %(computed) | 67.82% | 16.77% | -66.66% | -162.47% | -198.34% |
Data source: Financial Modeling Prep · Last updated: 2026-06-16 · USD · M
Explore more Panacea Life Sciences Holdings, Inc. data
About Panacea Life Sciences Holdings, Inc. (PLSH) Cash Flow Statement
Panacea Life Sciences Holdings, Inc. generated operating cash flow of $0.00B and free cash flow of $0.00B for 2025 — a FCF margin of 67.82%. Capital expenditure was $0.00B.
Frequently asked questions
PLSH · 4 questionsPanacea Life Sciences Holdings, Inc. generated free cash flow of $0.00B for 2025, down 10.4% year-over-year.
PLSH free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-16